BVU-28844-22373
3 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 681 / NE
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-29
Registered in v-safe
-
2021-01-29
Dose 1 — Pfizer-BioNTech
- 2021-01-29
- 2021-01-31
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
-
2021-02-19
Dose 2 — Pfizer-BioNTech
- 2021-08-01
-
2022-01-10
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-01-31
- 2022-01-31
- 2022-02-08
- 2022-02-14
- 2022-02-21
-
2022-04-11
Survey response — 3 months, dose 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: Just a small coldMedDRA releases: 2024-11 · check-in free text available
- 2022-07-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | No |
| 3 | 2022-01-10 | Pfizer-BioNTech | Flu |
Free text
Release 11 — 3 months, dose 3
Symptoms: Just a small cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release